Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial

John D. Roache, Martina Pavlicova, Aimee Campbell, Tse Hwei Choo, Michelle Peavy, Andrea S. Kermack, Edward V. Nunes, John Rotrosen

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds